Clinical Preconference

Saturday, July 14, 2012
Alzheimer’s Disease in Primary Care Settings

Overview

Designed for practicing physicians, this preconference will include information and sessions on the following areas:

• Research, including new diagnostic criteria, diagnostic process, disease-modifying drugs and what lies ahead.
• Early identification of Alzheimer's disease, including screening.
• Medical treatment of Alzheimer's disease, including disease-related treatments and behavioral treatments.
• Ongoing care management, including the role of the general practitioner, care planning, care environments, caregiver support and community resources.
• Research opportunities for general practitioners.

Target audience

All clinicians involved in the care of or research on individuals with memory or other cognitive complaints, including but not limited to neurologists, psychiatrists, radiologists, geriatricians, and neuropsychologists; as well as researchers, industry and regulatory agencies stakeholders, and others involved in the use of imaging techniques in the study of Alzheimer's disease, related disorders and normal aging.

Learning objectives

At the end of this educational activity, attendees should be able to:

• Recognize the importance and ethical considerations of early diagnosis.
• Explain the cognitive, functional and behavioral treatment of Alzheimer's disease.
• Identify the fundamentals of care management for persons with Alzheimer's.
• Recognize Alzheimer's research opportunities for general practitioners.

Accreditation statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and the Alzheimer's Association. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit designation

The Postgraduate Institute for Medicine designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of conflicts of interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.